Depressive behavior in mice due to immune stimulation is accompanied by reduced neural activity in brain regions involved in positively motivated behavior

Biol Psychiatry. 2006 Oct 15;60(8):803-11. doi: 10.1016/j.biopsych.2006.04.020. Epub 2006 Jun 30.

Abstract

Background: Immune stimulation inhibits positively motivated behavior and induces depressive illness. To help clarify the mechanism of these effects, neural activity in response to a positive stimulus was examined in brain regions associated with positively motivated activity defined on the basis of prior behavioral studies of central alpha1-adrenoceptor action.

Methods: Mice pretreated with either lipopolysaccharide or, for comparison, reserpine were exposed to a motivating stimulus (fresh cage) and subsequently assayed for fos expression and mitogen-activated protein kinase (MAPK) phosphorylation, two measures associated with alpha1-adrenoceptor-dependent neural activity, in several positive-activity-related (motor, piriform, cingulate cortex, nucleus accumbens, locus coeruleus) and stress-related brain regions (paraventricular hypothalamus, bed nucleus stria terminalis).

Results: Both lipopolysaccharide and reserpine pretreatment abolished fresh cage-induced fos expression and MAPK activation in the positive activity-related brain regions but enhanced these measures in the stress-related areas.

Conclusions: The results support the hypothesis that immune activation reduces alpha1-adrenoceptor-related signaling and neural activity in brain regions associated with positive activity while it increases these functions in stress-associated areas. It is suggested that neural activities of these two types of brain regions are mutually antagonistic and that a reciprocal shift toward the stress regions is a factor in the loss of positively motivated behaviors in sickness behavior and depressive illness.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adjuvants, Immunologic / pharmacology*
  • Adrenergic Uptake Inhibitors / pharmacology
  • Animals
  • Behavior, Animal / drug effects*
  • Brain / drug effects*
  • Brain / physiology*
  • Cerebral Cortex / drug effects
  • Cerebral Cortex / metabolism
  • Depression / chemically induced*
  • Depression / psychology*
  • Exploratory Behavior / drug effects
  • Lipopolysaccharides / pharmacology
  • Male
  • Mice
  • Mitogen-Activated Protein Kinases / metabolism
  • Motivation*
  • Neurons / drug effects*
  • Paraventricular Hypothalamic Nucleus / drug effects
  • Paraventricular Hypothalamic Nucleus / metabolism
  • Phosphorylation
  • Proto-Oncogene Proteins c-fos / biosynthesis
  • Reserpine / pharmacology

Substances

  • Adjuvants, Immunologic
  • Adrenergic Uptake Inhibitors
  • Lipopolysaccharides
  • Proto-Oncogene Proteins c-fos
  • Reserpine
  • Mitogen-Activated Protein Kinases